Expert InterviewREGN
Slingshot members are talking to an expert! The topic is:
Dissecting the Phase 3 Results of Regeneron's Olatorepatide (once-weekly GLP-1/GIP receptor dual agonist) for Obesity Treatment
Executed on:Mar 30, 2026 9:00 AM EDT
Call Duration:30 minutes
Expert Profile
ExpertBlinded Expert
Institution: Yale School of Medicine
- Assistant Professor at Yale University in the Section of Endocrinology
- Manages over 100+ patients annually with Type 2 Diabetes and Obesity
- Possesses additional training in obesity medicine and weight management; Research focus involves the comprehensive management of the interrelated disease processes of diabetes, obesity, and sleep disorders.
Interview Goal
This call will compare the results from the phase 3 clinical trial of Olatorepatide in patients with obesity to other weight loss medications.